BRD4: An emerging prospective therapeutic target in glioma

被引：39

作者：

Yang, Hua ^{[1
]}

Li Wei ^{[2
]}

Xun, Yang ^{[1
]}

Yang, Anping ^{[1
]}

You, Hua ^{[2
]}

机构：

[1] Foshan Univ, Sch Med, Dept Basic Med & Biomed Engn, Foshan 528000, Guangdong, Peoples R China

[2] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, 78 Heng Zhi Gang Rd, Guangzhou 510095, Guangdong, Peoples R China

来源：

MOLECULAR THERAPY-ONCOLYTICS | 2021年 / 21卷

基金：

中国国家自然科学基金;

关键词：

BROMODOMAIN INHIBITOR OTX015; ENHANCED EFFICACY; BET INHIBITOR; GLIOBLASTOMA; PROTEINS; NANOPARTICLES; COMBINATION; ACTIVATION;

D O I：

10.1016/j.omto.2021.03.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Despite advances in treatment, the prognosis for glioma patients remains poor. Bromodomain-containing protein 4 (BRD4), a member of the bromodomain and extraterminal (BET) protein family, plays an important role in controlling oncogene expression and genome stability. In recent years, numerous BRD4 inhibitors have entered clinical trials and achieved exciting results in tumor treatment. Recent clinical studies have shown that BRD4 expression in glioma is significantly higher than in the adjacent normal brain tissue. BRD4 inhibitors effectively penetrate the blood-brain barrier and target glioma tumor tissues but have little effect on normal brain tissues. Thus, BRD4 is a target for the treatment of glioma. In this study, we discuss the progress in the use of BRD4 inhibitors for glioma treatment, their mechanism of action, and their broad potential clinical application.

引用

页码：1 / 14

页数：14

共 70 条

[11] Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma [J].

Cheng, Zhixiang ;

Gong, Yuanying ;

Ma, Yufang ;

Lu, Kaihua ;

Lu, Xiang ;

Pierce, Larry A. ;

Thompson, Reid C. ;

Muller, Susanne ;

Knapp, Stefan ;

Wang, Jialiang .

CLINICAL CANCER RESEARCH, 2013, 19 (07) :1748-1759

[12] Neuroprotective effects of targeting BET proteins for degradation with dBET1 in aged mice subjected to ischemic stroke [J].

DeMars, Kelly M. ;

Yang, Changjun ;

Candelario-Jalil, Eduardo .

NEUROCHEMISTRY INTERNATIONAL, 2019, 127 :94-102

[13] Selective degradation of BET proteins with dBET1, a proteolysis-targeting chimera, potently reduces pro-inflammatory responses in lipopolysaccharide-activated microglia [J].

DeMars, Kelly M. ;

Yang, Changjun ;

Castro-Rivera, Carolina I. ;

Candelario-Jalil, Eduardo .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (01) :410-415

[14] Novel pyrano 1,3 oxazine based ligand inhibits the epigenetic reader hBRD2 in glioblastoma [J].

Deshmukh, Prashant ;

Mathur, Shruti ;

Gangadharan, Gejo ;

Krishnappa, Gopinatha ;

Nanjaiah, Nandakumar Dalavaikodihalli ;

Padmanabhan, Balasundaram .

BIOCHEMICAL JOURNAL, 2020, 477 (12) :2263-2279

[15] BRD4 and Cancer: going beyond transcriptional regulation [J].

Donati, Benedetta ;

Lorenzini, Eugenia ;

Ciarrocchi, Alessia .

MOLECULAR CANCER, 2018, 17

[16] Genome-wide transcriptional analysis of BRD4-regulated genes and pathways in human glioma U251 cells [J].

Du, Zhanhui ;

Song, Xiuxiang ;

Yan, Fangfang ;

Wang, Jingjing ;

Zhao, Yuxia ;

Liu, Shangming .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (05) :1415-1426

[17] Targeting Brd4 for cancer therapy: inhibitors and degraders [J].

Duan, Yingchao ;

Guan, Yuanyuan ;

Qin, Wenping ;

Zhai, Xiaoyu ;

Yu, Bin ;

Liu, Hongmin .

MEDCHEMCOMM, 2018, 9 (11) :1779-1802

[18] Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1 [J].

Fahey, Jonathan M. ;

Stancill, Jennifer S. ;

Smith, Brian C. ;

Girotti, Albert W. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (14) :5345-5359

[19] Selective inhibition of BET bromodomains [J].

Filippakopoulos, Panagis ;

Qi, Jun ;

Picaud, Sarah ;

Shen, Yao ;

Smith, William B. ;

Fedorov, Oleg ;

Morse, Elizabeth M. ;

Keates, Tracey ;

Hickman, Tyler T. ;

Felletar, Ildiko ;

Philpott, Martin ;

Munro, Shonagh ;

McKeown, Michael R. ;

Wang, Yuchuan ;

Christie, Amanda L. ;

West, Nathan ;

Cameron, Michael J. ;

Schwartz, Brian ;

Heightman, Tom D. ;

La Thangue, Nicholas ;

French, Christopher A. ;

Wiest, Olaf ;

Kung, Andrew L. ;

Knapp, Stefan ;

Bradner, James E. .

NATURE, 2010, 468 (7327) :1067-1073

[20] Oncolytic Virotherapy for the Treatment of Malignant Glioma [J].

Foreman, Paul M. ;

Friedman, Gregory K. ;

Cassady, Kevin A. ;

Markert, James M. .

NEUROTHERAPEUTICS, 2017, 14 (02) :333-344

← 1 2 3 4 5 6 7 →